Navigation Links
Aspirin Doesn't Guard Diabetics Against Heart Disease
Date:11/9/2008

aid Dr. Carl J. Lavie, medical director of cardiac rehabilitation at Ochsner Heart & Vascular Institute in New Orleans. "For some, the diabetes mellitus population does not seem to be gaining the expected aspirin benefit, at least in primary prevention. Certainly, there is proven aspirin benefit in secondary prevention. Right now, it would be hard to make a very strong case for low-dose aspirin, at least in the relatively healthy diabetic in primary prevention."

Indeed, the study authors themselves said that the role of aspirin as primary prevention in patients with type 2 diabetes is yet to be understood.

As with aspirin in the diabetic population, vitamin E and C supplements are widely used to prevent cardiovascular events, again without strong evidence to support the practice in low-risk individuals.

In the second study, 14,641 U.S. male doctors aged 50 or older were randomly assigned to receive 400 IU of vitamin E every other day and 500 milligrams of vitamin C every day or a placebo at the same intervals. The vast majority of participants had no history of cardiovascular disease.

After a mean follow-up of eight years, the researchers determined that neither vitamin had an effect on the incidence of major cardiovascular events or death, when compared with a placebo. This was true even of the 5.1 percent of men who had a history of cardiovascular disease.

There was, however, a 74 percent increase in the risk of hemorrhagic (bleeding) stroke among men in the vitamin E group.

"Based on this and other studies, there is absolutely no reason for patients to be taking E for cardioprotection, and if they are doing so, we should encourage them to stop, as I have been doing for the last five years or so," Lavie said. "The jury has still been out about C, but this certainly indicates no benefit, although no definite harm."

A representative for the supplements industry took a different view.


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

1

GOOD

Page: 1 2 3 4

Related medicine news :

1. Low-dose aspirin does not appear to reduce risk of CV events in patients with diabetes
2. Bayer Marketing Two Unapproved Aspirin Products: FDA
3. New CHARISMA Outcome Study Results Validate Aspirin Effect
4. Breakthrough Testing for Patients on Aspirin Therapy for Preventing Heart Attacks
5. Statement From Bayer(R) Aspirin Regarding the American Medical Associations New Aspirin Policy Resolution
6. Aspirin at Bedtime Lowers Blood Pressure
7. Anti-Clotting Drug as Good as Aspirin at Stopping Second Stroke
8. Daily Aspirin May Reduce Breast Cancer Risk
9. Daily aspirin may reduce risk of common type of breast cancer
10. Aspirin-like compounds increase insulin secretion in otherwise healthy obese people
11. Will botox be the aspirin of the 21st century?
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Aspirin Doesn't Guard Diabetics Against Heart Disease
(Date:5/25/2013)... The current residents of Back2Basics - Long Term Drug and ... came together Saturday, May 18th to celebrate the company's 3rd ... residents got up to thank Roy Duprez, CEO and Founder ... recovery, and giving them a second chance at life. , ... realizing the need for a long-term facility. What started ...
(Date:5/24/2013)... 25, 2013 The special 35% off ... products from Sublime Beauty®. The products include a ... and many of the ingredients are in fact organic. ... is dreaded by many women," says Kathy Heshelow, founder ... women can diminish their cellulite." The plan includes two ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 ShopPharmacyCounter.com PhenObestin ... experts ShopPharmacyCounter.com have announced price reductions on their popular ... store, which helps clients to lose weight as effortlessly ... PhenObestin 37.5 by more than 50%. , Bottles have ... limited time and all orders will receive free shipping. ...
(Date:5/24/2013)... This week is National EMS Week, which recognizes ... the best emergency care and to improve health communications ... to educate the public that all can play a ... first link, and a very important one. According to ... cardiac arrest can triple a victim’s chance of survival. ...
(Date:5/24/2013)... 2013 ResortQuest Real Estate® is proud ... Feher team at the firm’s Bethany Beach location. , ... her home in 1975. Her real estate career began ... aspects of the real estate business - receptionist, cleaning ... years, a licensed sales associate. , “I am ...
Breaking Medicine News(10 mins):Health News:Back2Basics Drug and Alcohol Rehabilitation Center Celebrates Their 3rd Anniversary 2Health News:"Get Ready for Summer Sale" at Sublime Beauty® Continues: New Cellulite Whisperer® Products 2Health News:ShopPharmacyCounter.com PhenObestin 37.5 Summer Sale Now On 2Health News:Acadian Medics Reunite with Miracle Baby 2Health News:Tammy Mushrush Joins ResortQuest Real Estate® and the Dayna Feher Team 2
... grant from the Agency for Healthcare Research and Quality ... the comparative effectiveness of positron emission tomography (PET) and ... on the diagnosis and management of cancer patients, but ... , "Comparative effectiveness research is essential to the future ...
... Intacs ... provided by Khanna institute in Beverly Hills , ... (Vocus) April 13, 2010 -- Khanna Institute, which expanded into Beverly Hills, ... that it is offering its Beverly Hills patients the opportunity to obtain a product known ...
... ... Videoconferencing System at the National Association of Broadcasters (NAB) show in Las ... lower price point than existing systems. Espresso HD uses patented next-generation ... ultra-fast set up and installation, better visual performance than competitive solutions using ...
... most of the brain tumor can often be removed surgically, ... this is that sporadic, infiltrative tumor cells will remain in ... University of Bonn have now subjected these ,forgotten, cells to ... were able to show that many of the fundamental properties ...
... , PHILADELPHIA Molecular biologist Jonathan Brody, Ph.D., assistant ... Thomas Jefferson University, has been awarded a 2010 Pancreatic ... (AACR) Career Development Award in memory of Skip Viragh. ... to help support his innovative research in pancreatic cancer. ...
... ... 80% of Women Enjoy Reading or Viewing Pornography; 73% Wish They Were Having More Sex. ... San Francisco, CA (PRWEB) April 13, 2010 ... a copy of What Women Really Want in Bed: The Surprising Secrets Women Wish Men ...
Cached Medicine News:Health News:SNM receives grant from AHRQ for comparative effectiveness research 2Health News:Khanna Institute to Provide Intacs Corneal Implants in Beverly Hills 2Health News:Khanna Institute to Provide Intacs Corneal Implants in Beverly Hills 3Health News:HD Telepresence Gets More Affordable for SMBs: XVD Espresso HD Delivers Higher Performance at Lower Costs than Traditional Solutions 2Health News:HD Telepresence Gets More Affordable for SMBs: XVD Espresso HD Delivers Higher Performance at Lower Costs than Traditional Solutions 3Health News:HD Telepresence Gets More Affordable for SMBs: XVD Espresso HD Delivers Higher Performance at Lower Costs than Traditional Solutions 4Health News:Brain cancer: Study focuses on forgotten cells 2Health News:Jefferson researcher receives 2010 Pancreatic Cancer Action Network-AACR Career Development Award 2Health News:'What Women Really Want In Bed' Is A Man's Guide To Giving Her The Sex She Wants 2Health News:'What Women Really Want In Bed' Is A Man's Guide To Giving Her The Sex She Wants 3Health News:'What Women Really Want In Bed' Is A Man's Guide To Giving Her The Sex She Wants 4
(Date:5/24/2013)... , May 24, 2013  Auxilium Pharmaceuticals, Inc. (Nasdaq: ... will participate in the Deutsche Bank Health Care Conference ... Waterfront Hotel.  Mr. Adrian Adams , ... an overview of the Company and its product pipeline ...   (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) ...
(Date:5/23/2013)... 3SBio Inc. (NASDAQ: SSRX ... China -based biotechnology company focused on ... today that, at an extraordinary general meeting held ... favor of the proposal to authorize and approve ... dated February 8, 2013, among Decade Sunshine Limited, ...
(Date:5/23/2013)... , May 23, 2013  Haemonetics Corporation (NYSE: ... , CFO & EVP-Business Development, will present at The Deutsche ... Boston, MA on May 29, 2013 ... ) The public may access Mr. Lindop,s ... About Haemonetics Haemonetics (NYSE: HAE ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 43SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3
... * Statistically significant reduction in sedation during ... * Statistically significant reduction in nausea in ... Cambridge, UK, 8th June 2007 - CeNeS ... company, announces,additional data from post-hoc analysis of ...
... Ala.--(BUSINESS WIRE)--Jun 8, 2007 - ProEthic,Pharmaceuticals, Inc., ... develops, licenses, and markets niche,prescription products, today ... the Company's product candidate for the treatment,of ... two poster,presentations at the American Headache Society's ...
Cached Medicine Technology:Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 2Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 3Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 4Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 5Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 6Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 7ProEthic Pharmaceuticals Presents Positive Data for PRO-513 at,American Headache Society Meeting 2ProEthic Pharmaceuticals Presents Positive Data for PRO-513 at,American Headache Society Meeting 3ProEthic Pharmaceuticals Presents Positive Data for PRO-513 at,American Headache Society Meeting 4
Intended for the quantitative determination of uric acid in serum or plasma. Reaction: endpoint. Wavelength: 520 nm. Linearity: 20 mg/dL (1190 mol/L). Single vial, dry powder reagent....
The Mikro 20 line of centrifuges has 4 models for microlitre applications complete with rotor. Whether cryo, PCR or standard micro tubes, it is the appropriate centrifuge of choice with angle rotor....
... Engineered for small and medium volume laboratories, ... 1010 System offers the speed, simplicity and ... requirements. Compact yet powerful, the Elecsys 1010 ... rapid response assays to routine testing without ...
The Dimension RxL Max is an integrated chemistry system and is the most powerful and technologically advanced Dimension analyze with new standard for excellence in clinical diagnostics. Simply put, t...
Medicine Products: